(Q43289038)

18 November 2017

title

Vardenafil-induced relaxation and cyclic nucleotide levels in normal and obstructed rat urinary bladder (English)

1 reference

18 November 2017

3

1 reference

18 November 2017

Viktoria Werkström

1

1 reference

18 November 2017

Petter Hedlund

series ordinal

2

1 reference

18 November 2017

Karl-Erik Andersson

series ordinal

4

1 reference

18 November 2017

publication date

19 August 2009

1 reference

18 November 2017

number of pages

6

1 reference

based on heuristic

inferred from page(s)

published in

BJU International

1 reference

18 November 2017

volume

104

1 reference

18 November 2017

issue

11

1 reference

18 November 2017

page(s)

1740-1745

1 reference

Update on phosphodiesterase (PDE) isoenzymes as pharmacologic targets in urology: present and future

18 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2009.08651.X

A Norwegian national cohort of 3198 women treated with home-managed electrical stimulation for urinary incontinence--demography and medical history.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2009.08651.X

Pharmacology of the lower urinary tract: basis for current and future treatments of urinary incontinence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2009.08651.X

Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2009.08651.X

Characterization and functional role of androgen-dependent PDE5 activity in the bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2009.08651.X

Phosphodiesterase 1 inhibition in the treatment of lower urinary tract dysfunction: from bench to bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2009.08651.X

Phosphodiesterase 5 in the female pig and human urethra: morphological and functional aspects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2009.08651.X

A randomised, placebo-controlled study to assess the efficacy of twice-daily vardenafil in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2009.08651.X

Simultaneous registration of intraabdominal and intravesical pressures during cystometry in conscious rats--effects of bladder outlet obstruction and intravesical PGE2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2009.08651.X

Sildenafil citrate improves erectile function and urinary symptoms in men with erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: a randomized, double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2009.08651.X

Endogenous nitric oxide/cGMP signalling in the guinea pig bladder: evidence for distinct populations of sub-urothelial interstitial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2009.08651.X

Alterations to network of NO/cGMP-responsive interstitial cells induced by outlet obstruction in guinea-pig bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2009.08651.X

Role of the urothelium in bladder function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2009.08651.X

The clinical pharmacokinetics of phosphodiesterase-5 inhibitors for erectile dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2009.08651.X

Inhibition of neuroeffector transmission in human vas deferens by sildenafil

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2009.08651.X

10.1111/J.1464-410X.2009.08651.X

21 January 2018

Identifiers

DOI

1 reference

18 November 2017

1 reference